Low quality pharmaceuticals are a global problem
The World Health Organization estimates that 10-30% of the pharmaceuticals that are purchased in the developing world are substandard or outright fake drugs. Many countries in the developing world do not have the technological infrastructure or regulatory resources to keep low quality medicines off the market shelves. And since the pharmaceutical trade is a lucrative global market, low quality medicine can cross borders and harm people anywhere in the world.
We are making tools to solve this problem.
Paper analytical devices (PADs) are test cards that can quickly determine whether a drug tablet contains the correct medicines. They are cheap and easy to use. They don't require power, chemicals, solvents, or any expensive instruments, so they can be deployed rapidly at large scale whereever a problem with pharmaceutical quality is suspected.
We are leveling the playing field.
These little test cards could change the balance of power between sellers and buyers. Right now, most buyers have to trust what the seller tells them about the quality of the pharmaceuticals they purchase. Unscrupulous manufacturers and distributors know that there is little chance that their medicines will be screened in a lab. These paper test cards don't need a lab, and they will enable people all over the world to quickly detect low quality medicines and remove them from the market.
The United States Pharmacopeia has selected Nick Myers as one of three USP Global Fellows in 2014-2015. Nick will develop a new type of paper-based test that can detect pharmaceuticals that don't contain the right amount of active ingredients. When a person buys an antibiotic, that product ought to contain the right quantity of medicine. But more than one in five of the samples from our field study site in western Kenya are substandard--mostly underdosed. …